Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome

LEMSTROVÁ, R., V. BRYNYCHOVA, D. HUGHES, V. HLAVAC, P. DVORAK, J. DOHERTY, H. MURRAY, M. CROCKARD, M. OLIVERIUS, J. HLAVSA, E. HONSOVA, J. MAZANEC, Z. KALA, M. LOVEČEK, R. HAVLÍK, J. EHRMANN, O. STROUHAL, P. SOUCEK, B. MELICHAR, B. MOHELNÍKOVÁ DUCHOŇOVÁ